Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

Publication date: July 2020Source: The Lancet Neurology, Volume 19, Issue 7Author(s): Tali Cukierman-Yaffe, Hertzel C Gerstein, Helen M Colhoun, Rafael Diaz, Luis-Emilio García-Pérez, Mark Lakshmanan, Angelyn Bethel, Denis Xavier, Jeffrey Probstfield, Matthew C Riddle, Lars Rydén, Charles Messan Atisso, Stephanie Hall, Purnima Rao-Melacini, Jan Basile, William C Cushman, Edward Franek, Matyas Keltai, Fernando Lanas, Lawrence A Leiter
Source: The Lancet Neurology - Category: Neurology Source Type: research